Determination of Sensitivity of Сlinical Strains of S. aureus Isolated from Patients with Orthopedic and Traumatological Pathology to the Antibacterial Agent “Piophagus”
ARTICLE PDF (Українська)

Keywords

bacteriophages, antibiotic resistance, infectious complications, phage therapy, clinical trials.

How to Cite

Liutko , O., Vytrak , K., & Mytiakyna , Y. (2020). Determination of Sensitivity of Сlinical Strains of S. aureus Isolated from Patients with Orthopedic and Traumatological Pathology to the Antibacterial Agent “Piophagus”. Herald of Orthopaedics, Traumatology and Prosthetics, (1(104), 30-38. https://doi.org/10.37647/0132-2486-2020-104-1-30-38

Abstract

Summary. The resistance of clinical microorganism strains isolated in modern hospitals to the corresponding antimicrobial agents, namely antibiotics, is increasing from year to year. Knowledge of the existence of a natural antimicrobial agent that can penetrate the necessary parts of the body and selectively fight pathogens is very desirable in modern medicine. Bacteriophages are one of the most promising alternatives to antibiotics for practical use. In the past, testing of phage therapy has already taken place with the implementation of numerous experimental and practical studies. However, the lack of standardized standards and their planned implementation can explain the infrequent use in practice of this method in the treatment of infectious diseases or postoperative infectious complications at present. A limitation is also the fact that the therapeutic effect after treatment with bacteriophages varies widely and has certain features. This, in general, is associated with the features of different loci when using such drugs and various sensitivity of microorganism strains to a single phage or their combination. Today, there is a better understanding of the pharmacology, immunology, safety and potential of bacterial resistance of phages. There is a growing number of well-performed clinical trials describing the effectiveness of phage therapy. New technologies provide tools to optimize the treatment strategies. The work analyzes the sensitivity of clinical strains of S. aureus isolated from patients with orthopedic and traumatological pathology, and preliminary generalizations are made. The revealed patterns can be used as the results of standardized monitoring of clinical strains of S. aureus in the case of a decrease in the effectiveness of antibiotic therapy in accordance with modern requirements and the transition to phage therapy in practice.

https://doi.org/10.37647/0132-2486-2020-104-1-30-38
ARTICLE PDF (Українська)

References

Volk A. A., Boichenko M. S., Matveeva Y. V., Zhuk A. V., Boichenko S. V. Bakteriofahy: nova paradyhma ta perevahy pered antybiotykamy u likuvalno-profilaktychnykh tsiliakh // Naukoiemni tekhnolohii .- № 2 (34). – 2017. – p. 150-157

Aslanov B.I., Zueva L.P., Kafty`reva L.A., Bojczov A.G., Akimkin V.G., Dolgij A.A., Brusina E.B., Drozdova O.M. Raczional`noe primenenie bakteriofagov v lechebnoj i protivoe`pidemicheskoj praktike // Federal`ny`e klinicheskie rekomendaczii. – Moskva. – 2014. – 39 p.

Mendzy`brodski R., Borisovskij Y., Veber-Dombrovskaya B., Fortuna V., Letkevich S., Shufnarovskij K. i dr. Klinicheskie aspekty` fagoterapii . Adv. Virus Res. 2012. - 83 , 73–121. 10.1016 / B978-0-12-394438-2.00003-7

M.P. Pokrovskaya, L.S.Kaganova, M.A. Morozenko, A.G. Bulgakova, E.E. Skaczenko // Lechenie ran bakteriofagom NARKOMZDRAV SSSR Gosudarstvennoe izdatel`stvo mediczinskoj literaturi. Moskva. – 1941. Leningrad. – 70 p.

Rohde C, Resch G, Pirnay JP, Blasdel BG, Debarbieux L, Gelman D, Górski A, Hazan R, Huys I, Kakabadze E, Łobocka M, Maestri A, Almeida GMF, Makalatia K, Malik DJ, Mašlaňová I, Merabishvili M, Pantucek R, Rose T, Štveráková D, Van Raemdonck H, Verbeken G, Chanishvili N. Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains. // Viruses. 2018 Apr 5;10(4). pii: E178. doi: 10.3390/v10040178.

Veber-Dombrovskaya B., Mul`chik M., Gurskij A. Bakteriofagovaya terapiya bakterial`ny`kh infekczij: obnovlenie opy`ta nashego instituta. Arkhipelag Immunol. Ther. Exp. 2000. - 48 , 547–551.

Morozova V.V., Vlassov V.V. and Tikunova N.V. Applications of Bacteriophages in the Treatment of Localized Infections in Humans. // Frontiers in Microbiology. - August 2018. - Volume 9. - Article 1696. - p. 1-8.

Van Bellegem D.D., Kliment F., Merabishvili M., Lavin R., Vanechut M. Pro- i protivovospalitel`ny`e reakczii mononuklearny`kh kletok perifericheskoj krovi, induczirovanny`e fagami Staphylococcus aureus i Pseudomonas aeruginosa . 2017 Sci. Otchet 7 : 8004.10.1038 / s41598-017-08336-9

R. Nir-Paz, D. Gelman, A. Khouri, B. M Sisson, J. Fackler, S. Alkalay-Oren, L. Khalifa, A. Rimon, O. Yerushalmy, R. Bader. Successful Treatment of Antibiotic-resistant, Poly-microbial Bone Infection With Bacteriophages and Antibiotics // Combination Clinical Infectious Diseases, Volume 69, Issue 11, 1 December 2019, Pages 2015–2018

Derkach S.A., Voronkina I.A., Kotsar O.V., Krylova I.A., Holovenkina N.A., Holovakhina L.M. Chutlyvist shtamiv stafilokokiv, zbudnykiv hniino-zapalnykh infektsii, do komertsiinykh preparativ bakteriofahiv // Annals of Mechnikov Institute. - 2013. - № 2. – p.40-44.

D. Romero-Calle, R. G. Benevides, A. Góes-Neto, and C. Billington. Bacteriophages as Alternatives to Antibiotics in Clinical Care // Antibiotics (Basel) . 2019 Sep; 8(3): 138.

Midlenko V.I., Shevalaev G.A., Efremov I.M. Chuvstvitel`nost` k preparatam bakteriofagov vozbuditelej oslozhnenij u bol`ny`kh posle travm i operativny`kh vmeshatel`stv na oporno-dvigatel`nom apparate // Fundamental`ny`e issledovaniya. – 2013. – № 9-5. – p.871-874

O.V. Lihonenko, I. I. Dihtiar, D. M. Ivashchenko, O. O. Lihonenko. Vykorystannia bakteriofahiv u kompleksi likuvannia khronichnykh ran // Shchomisiachnyi naukovo-praktychnyi zhurnal Klinichna khirurhiia. - 2011. - № 11 (824) lystopad. - p.29.

Vorobiei Y., Voronkova O., Sirokvasha O., Vinnikov A. Likuvalno-profilaktychni preparaty bakteriofahiv // Visnyk Lvivskoho universytetu. Seriia biolohichna. -2014. Vypusk - 64. p. 52–66.

Gabrie`lyan N.I., Gorskaya E.M., Czirul`nikova O.M. Vozmozhnosti ispol`zovaniya bakteriofagov v khirurgii i transplantologii // Vestnik Transplantologii i iskusstvenny`kh organov. Moskva. - 2012. – Tom XIV № 1– p. 107-113.

Bryusov P.G., Zubriczkij V.F., Nizovoj A.V., Fominy`kh E.M. Fagoprofilaktika i lechenie bakteriofagov khirurgicheskikh infekczij . Mil. Med. J. 2011. - № 4 , p. 34–39.

Elizabeth Kutter, Daniel De Vos, Guram Gvasalia. Phage Therapy in Clinical Practice: Treatment of Human Infections. // Current Pharmaceutical Biotechnology, 2010, №11, p. 69-86

Wolcott RD, Hanson JD, Rees EJ, Koenig LD, Phillips CD, Wolcott RA, et al. Analiz mikrobioty` khronicheskoj rany` u 2963 paczientov metodom pirosekvenirovaniya 16S rDNK .Vosstanovlenie rany` Regen. 2016.- № 24 , p. 163–174.

I.S. Vorobiei, O.S. Voronkova, T. M. Polishko, A. I. Vinnikov. Porivniannia chutlyvosti plivkoutvoriuiuchykh i neplivkoutvoriuiuchykh shtamiv Staphylococcus spp. do likuvalnykh preparativ bakteriofahiv // Bioriznomanittia ta rol tvaryn v ekosystemakh: Materialy VII Mizhnarodnoi naukovoi konferentsii. – Dnipropetrovsk: Adverta, 2013.p. 8-9.

Rakhim K., Kasim M., Rakhman Kh., Khan T.A., Akhmad I., Khan N. i dr. Ustojchivost` k antimikrobny`m preparatam sredi bakterij, vy`rabaty`vayushhikh ae`robny`e bioplenki, vy`delenny`kh iz khronicheskikh ran v bol`niczakh tretichnogo urovnya v Peshavare, Pakistan . J. Ukhod za ranoj. 2016. - № 25 , p. 480–486.

Samokhin A.G., Fyodorov E.A., Kozlova Yu.N., Tikunova N.V., Pavlov V.V., Morozova V.V., Kret`en S.O. Primenenie liticheskikh bakteriofagov pri khirurgicheskom lechenii paraproteznoj infekczii endoproteza tazobedrenogo sustava (pilotnoe izdanie) // Sovremenny`e problemy` nauki i obrazovaniya. E`lektronny`j nauchny`j zhurnal. ISSN 2070-7428– 2016. – № 6.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.